
Arthur J. Gallagher & Co.
AJG · NYSE · Insurance
Quotes delayed up to 15 min. Updated 16 Nov, 16:00 New York time
- Market cap
- $72,5 bn
- Div. yield
- 0,9%
- Year to date
- +9,3%
Ratio score
based on 6 metrics as of 16.11.2026 ·
Verdict by our methodology based on current metrics. Not an investment recommendation.
Key metrics
3 ✓ · 2 — · 1 ✕ · 4 n/a · hover over a row or tap it to see the trend
All metrics
| Metric | Value | 5-year median | Industry median |
|---|---|---|---|
| P/E TTM | 42,7 | 42,6 | 12,9 |
| Forward P/E | 19,0 | — | 12,6 |
| PEG | 2,6 | — | 1,6 |
| P/S | 4,6 | 4,8 | 1,9 |
| EV/EBITDA | 19,6 | 22,5 | 11,0 |
| P/FCF | 24,8 | — | 9,2 |
| P/B | 3,0 | 4,1 | 2,0 |
Industry median — across 22 profitable companies in “Insurance” in Ratio. Revenue and EPS forecasts for future years and the number of employees are in the paid data plan.
Price chart
Compare with
Choose a stock
Closing prices adjusted for splits and dividends. The S&P 500 index and the intraday chart come later.
Analysts
Ratings, 29 analysts
- Buy
- 21
- Hold
- 8
- Sell
- 0
Beat the EPS forecast in 1 of the last 4 quarters
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| Q3 2026 | 3,03 | 3,00 | Down −0,9% |
| Q2 2026 | 2,84 | 2,84 | Down 0,0% |
| Q1 2026 | 4,47 | 4,47 | Down 0,0% |
| Q4 2025 | 2,37 | 2,38 | Up +0,3% |
Price targets and yearly revenue and EPS forecasts are in the paid data plan. These are analysts' opinions, not our verdict.
Financials in charts
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3,98 bn | 4,00 bn | 4,76 bn | 3,63 bn | 3,37 bn | 3,22 bn | 3,73 bn | 2,72 bn | 2,81 bn | 2,78 bn | 3,26 bn | 2,43 bn |
| EPS | 1,55 | 1,25 | 3,16 | 0,58 | 1,04 | 1,40 | 2,72 | 1,10 | 1,39 | 1,27 | 2,74 | −0,16 |
| Margin | 10,1% | 8,1% | 17,3% | 4,2% | 8,1% | 11,4% | 18,9% | 9,5% | 11,1% | 10,2% | 18,7% | −1,3% |
| FCF | 1,34 bn | 10,0 m | 957 m | 753 m | 731 m | −426 m | 872 m | 739 m | 935 m | 120 m | 789 m | 694 m |
From SEC reports. TTM is the sum of 4 quarters; a year is TTM at the end of the calendar year. Forecast bars are in the paid data plan.
Owners
Ownership structure and major holders (13F filings) are in the paid data plan. They are not part of the score or the traffic light.
Insider trades over 12 months
Over 12 months: no purchases, sales $46,2 m.
| Name | Amount | Shares | Price |
|---|---|---|---|
| pietrucha susan e9 Nov 2026 · sale | $4,24 m | 15 020 | $282,30 |
| ziebell william f4 Nov 2026 · sale | $6,74 m | 23 510 | $286,63 |
| mead christopher e2 Nov 2026 · sale | $2,12 m | 7 590 | $279,72 |
| howell douglas k2 Nov 2026 · sale | $135 749 | 492 | $275,91 |
| howell douglas k2 Nov 2026 · sale | $3,68 m | 13 374 | $275,30 |
| howell douglas k2 Nov 2026 · sale | $4,71 m | 17 130 | $275,00 |
| cary richard c15 Sep 2026 · sale | $252 858 | 1 000 | $252,86 |
| hudson scott r2 Sep 2026 · sale | $3,17 m | 12 000 | $264,13 |
| bay walter d.24 Aug 2026 · sale | $3,24 m | 12 000 | $270,08 |
| mead christopher e19 Aug 2026 · sale | $899 587 | 3 500 | $257,03 |
| cary richard c2 Jun 2026 · sale | $618 000 | 3 000 | $206,00 |
| hudson scott r6 Mar 2026 · sale | $864 766 | 3 800 | $227,57 |
| mead christopher e5 Mar 2026 · sale | $908 472 | 4 000 | $227,12 |
| gallagher j patrick jr2 Mar 2026 · sale | $6,32 m | 27 450 | $230,31 |
| mead christopher e23 Dec 2025 · sale | $1,03 m | 4 000 | $258,11 |
SEC Form 4. Titles and trading plans are not in the data. They are not part of the score or the traffic light.
About the company
- Industry
- Insurance
- Exchange
- NYSE
- Country
- US
- IPO date
- 21 Jun 1984
- Website
- www.ajg.com
Company description, revenue by segment and region, and the CEO will come later.
Earnings
- Next report
- date not announced
An AI summary of the earnings call will come later.
Peers
| Company | Price | ||||
|---|---|---|---|---|---|
AONAon plc | $343,12 | 79★★★★★★★★★would consider | 18,3 | +3,8% | 22,6% |
ALLAllstate | $270,43 | 71★★★★★★★★★would consider | 5,7 | +5,1% | 16,6% |
METMetLife | $101,45 | 86★★★★★★★★★★would consider | 12,4 | +14,8% | 6,2% |
AFLAflac | $128,08 | 29★★★★★★★would not consider | 13,0 | −6,2% | 21,2% |
MRSHMarsh McLennan | $209,88 | 58★★★★★★★★would watch | 24,9 | +7,6% | 14,2% |
Ratio — a score by our methodology, not an investment recommendation.




